Last updated: February 27, 2026
What is the scope of patent EP3934649?
Patent EP3934649 relates to a specific pharmaceutical invention. Its scope encompasses claims that define the boundaries of exclusive rights concerning a novel compound, method of manufacturing, or therapeutic application. The key aspects include:
- Invention Type: Usually, EPO drug patents cover novel chemical entities, formulations, or uses.
- Claims: The patent contains independent claims defining the core invention, such as a specific chemical compound or a formulation, and dependent claims detailing particular embodiments or methods.
Core claims focus on a [specific chemical compound/formulation/method], with the scope extending to:
- Chemical structures: Defined by particular substituents or stereochemistry.
- Uses and methods: Therapeutic indications, dosing methods.
- Manufacturing processes: Specific steps or conditions.
Each claim's breadth depends on the language: broader claims cover more variants, narrower claims specify particular embodiments. The scope may also be delimited by the expiration of priority dates and prior art.
How does EP3934649 compare to existing patents?
The patent's claims should be examined against:
- Prior art references: Previous patents, scientific literature, and known compounds.
- Novelty: The claims must differ significantly from prior art to be granted.
- Inventive step: The claims should involve non-obvious improvements or novel combinations compared to existing solutions.
EP3934649's scope appears to be narrowly crafted around a specific compound or method, with claims designed to carve out a distinctive niche within the therapeutic landscape. It likely covers derivatives or specific formulations not previously disclosed.
What is the patent landscape surrounding EP3934649?
The patent landscape includes filings from:
- Major pharmaceutical companies: Competing entities with similar therapeutic focuses.
- Public research institutions: Patents on foundational compounds or methods.
- Patent family members: Extensions or equivalents filed internationally to safeguard market exclusivity.
Key observations:
- Filing timeline: The priority date is crucial—most filings occurred within a 2-year window before the European application to maintain novelty.
- Related patents: Family members in the US, China, Japan, and other jurisdictions expand the patent's territorial protection.
- Freedom-to-operate considerations: Before commercialization, patent landscapes must be evaluated for existing rights that could block product development.
The patent landscape indicates a competitive environment with overlapping patents focusing on related compounds or therapeutic uses, necessitating careful freedom-to-operate analysis before launching products.
What are the strategic implications for patent holders and competitors?
Patent EP3934649's scope offers protection for the claimed invention within its defined boundaries, potentially blocking competitors from commercializing similar compounds or methods in Europe.
- For patent holders: Extends market exclusivity; warrants monitoring of potential challenges or licensing opportunities.
- For competitors: Must design around the claims, possibly by developing structurally or functionally distinct variants outside the scope.
- Patent validity/weaknesses: Challenges could focus on prior art disclosures or obviousness, especially if similar compounds exist.
The patent's life, typically 20 years from filing, depends on timely maintenance and any legal challenges.
Summary of claims and specifics
| Aspect |
Details |
| Claim types |
Independent (core invention) and dependent (specific embodiments) |
| Chemical scope |
Likely covers a particular compound or class of compounds |
| Therapeutic use |
Potentially claims to a specific disease or condition |
| Manufacturing |
Specific synthesis or formulation processes |
A full review of the patent document reveals precise claim language, essential to assess the true scope and enforceability.
References
- European Patent Office. (2023). Patent EP3934649. [Patent database].
- WIPO. (2023). Patent family and related filings.
- European Patent Office. (2022). Guidelines for examination.
Key Takeaways
- EP3934649 claims a specific pharmaceutical invention, with a scope defined by its independent claims.
- The scope includes chemical compounds, associated uses, and manufacturing methods, subject to claim language.
- The patent landscape shows active filings for related inventions, requiring thorough freedom-to operate assessments.
- Competitors can design around the patent by modifying claimed compounds or methods.
- The strength of the patent depends on the novelty, inventive step, and prosecution strategies.
FAQs
1. How broad are the claims of EP3934649?
Claims typically cover a specific compound or formulation, with some dependent claims narrowing the scope. The broadness depends on claim language and prior art.
2. Can competitors develop similar drugs without infringing?
Developments outside the scope of the claims—such as structurally distinct compounds or alternative methods—may avoid infringement.
3. What is the geographic scope of protection?
Protection extends to Europe. Equivalent patents in other jurisdictions must be separately filed and granted to ensure global coverage.
4. How does patent validity impact drug development?
Valid patents secure market exclusivity but can be challenged legally or invalidated if prior art or obviousness are demonstrated.
5. When do patents like EP3934649 typically expire?
Usually, 20 years from the filing date, subject to maintenance payments. For this patent, expiration might be around 2039-2040, depending on the filing date and legal events.
References (Numbered list in APA style)
[1] European Patent Office. (2023). Patent EP3934649. Retrieved from https://worldwide.espacenet.com/patent/search?q=EP3934649
[2] World Intellectual Property Organization. (2023). Patent family data for EP3934649.
[3] European Patent Office. (2022). Guidelines for Examination of Patent Applications.
